Michael Pablos Quiles
Nephrology · San Juan, PRNPI 1841738291
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 75 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 18.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,075, more than ten times the $68 reported in 2019.
Across 75 payments — averaging $42.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aurinia Pharma U.S., Inc.$584
- Bayer$477
- Johnson & Johnson$449
- Ardelyx, Inc.$255
- Travere Therapeutics, Inc.$251
- Otsuka America Pharmaceutical, Inc.$237
- plus $950 from 14 others
What the payments were for
- Food & beverage$3,202100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aurinia Pharma U.S., Inc. | 15 | $584 |
| Bayer | 12 | $477 |
| Johnson & Johnson | 13 | $449 |
| Ardelyx, Inc. | 6 | $255 |
| Travere Therapeutics, Inc. | 2 | $251 |
| Otsuka America Pharmaceutical, Inc. | 2 | $237 |
| AstraZeneca(2 entities) | 5 | $206 |
| Mylan Specialty L.p. | 1 | $125 |
| Boston Scientific | 2 | $122 |
| E.r. Squibb & Sons, L.L.C. | 1 | $115 |
| Veloxis Pharmaceuticals, Inc. | 3 | $94 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $92 |
| Merck | 3 | $62 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $23 |
| OPKO Pharmaceuticals, LLC | 1 | $22 |
| Apellis Pharmaceuticals, Inc. | 1 | $20 |
| Novartis | 1 | $18 |
| PBG Puerto Rico LLC | 1 | $18 |
| Pfizer | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JYNARQUE$237
- Filspari$146
- Yupelri$125
- XARELTO$125
- FARXIGA$125
- Kerendia$123
- LUPKYNIS$123
- XPHOZAH 30 MG$122
- WATCHMAN Access System$104
How this compares
$3,202 in reported general payments places this provider in the 75th percentile of 161 nephrology providers in Puerto Rico.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nifedipine ErNifedipine | 14 | $158 |
| Furosemide | 12 | $21 |
Paid to pharmacies, not to this prescriber.
Other nephrology in San Juan
- Carlos Rivera BermudezSan Juan$7K
- Lisandro Montalvo SanchezSan Juan$4K
- Glenda Miranda-TiradoSan Juan$4K
- Rodolfo TrocheSan Juan$3K
- Victor Flores CheverezSan Juan$3K
- Jesus Vega-ColonSan Juan$3K
- Orlando Camacho-GeckSan Juan$3K
- Antonio DiazSan Juan$3K
- Maria RiveraSan Juan$3K
- Eddie Rodriguez CastroToa Baja$591K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.